Hookipa Pharma Shares Owned By Insiders vs. Price To Earning

HOOK Stock  USD 2.48  0.07  2.75%   
Based on the key profitability measurements obtained from Hookipa Pharma's financial statements, Hookipa Pharma may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in January. Profitability indicators assess Hookipa Pharma's ability to earn profits and add value for shareholders. Sales General And Administrative To Revenue is expected to rise to 1.18 this year, although the value of Price To Sales Ratio will most likely fall to 3.61. At this time, Hookipa Pharma's Net Interest Income is quite stable compared to the past year. Interest Income is expected to rise to about 5.2 M this year, although the value of Net Loss will most likely fall to (72.5 M).
For Hookipa Pharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Hookipa Pharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Hookipa Pharma utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Hookipa Pharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Hookipa Pharma over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis.
For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hookipa Pharma. If investors know Hookipa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hookipa Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.67)
Revenue Per Share
4.403
Quarterly Revenue Growth
(0.52)
Return On Assets
(0.20)
Return On Equity
(0.49)
The market value of Hookipa Pharma is measured differently than its book value, which is the value of Hookipa that is recorded on the company's balance sheet. Investors also form their own opinion of Hookipa Pharma's value that differs from its market value or its book value, called intrinsic value, which is Hookipa Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hookipa Pharma's market value can be influenced by many factors that don't directly affect Hookipa Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hookipa Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hookipa Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hookipa Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Hookipa Pharma Price To Earning vs. Shares Owned By Insiders Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Hookipa Pharma's current stock value. Our valuation model uses many indicators to compare Hookipa Pharma value to that of its competitors to determine the firm's financial worth.
Hookipa Pharma is one of the top stocks in shares owned by insiders category among its peers. It is rated # 2 in price to earning category among its peers reporting about  0.56  of Price To Earning per Shares Owned By Insiders. The ratio of Shares Owned By Insiders to Price To Earning for Hookipa Pharma is roughly  1.78 . Comparative valuation analysis is a catch-all technique that is used if you cannot value Hookipa Pharma by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Hookipa Price To Earning vs. Shares Owned By Insiders

Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Hookipa Pharma

Insiders Shares

 = 

Executives Shares

+

Employees

 = 
21.43 %
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

Hookipa Pharma

P/E

 = 

Market Value Per Share

Earnings Per Share

 = 
12.06 X
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.

Hookipa Price To Earning Comparison

Hookipa Pharma is currently under evaluation in price to earning category among its peers.

Hookipa Pharma Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Hookipa Pharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Hookipa Pharma will eventually generate negative long term returns. The profitability progress is the general direction of Hookipa Pharma's change in net profit over the period of time. It can combine multiple indicators of Hookipa Pharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-7.9 M-8.3 M
Net Interest Income4.6 M4.8 M
Interest IncomeM5.2 M
Operating Income-97.7 M-92.8 M
Net Loss-69.1 M-72.5 M
Income Before Tax-81.2 M-77.2 M
Total Other Income Expense Net16.5 M17.3 M
Net Loss-58.4 M-61.3 M
Net Loss-81.6 M-77.5 M
Income Tax Expense368 K386.4 K
Non Operating Income Net Other8.2 M6.9 M
Change To NetincomeM5.4 M
Net Loss(8.63)(9.06)
Income Quality 0.71  0.88 
Net Income Per E B T 0.90  0.80 

Hookipa Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Hookipa Pharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Hookipa Pharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Hookipa Pharma's important profitability drivers and their relationship over time.

Use Hookipa Pharma in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Hookipa Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hookipa Pharma will appreciate offsetting losses from the drop in the long position's value.

Hookipa Pharma Pair Trading

Hookipa Pharma Pair Trading Analysis

The ability to find closely correlated positions to Hookipa Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Hookipa Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Hookipa Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Hookipa Pharma to buy it.
The correlation of Hookipa Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Hookipa Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Hookipa Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Hookipa Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Hookipa Pharma position

In addition to having Hookipa Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Warren Buffett Holdings Thematic Idea Now

Warren Buffett Holdings
Warren Buffett Holdings Theme
A long-term portfolio of publicly-traded stocks on US exchanges that are owned by Warren Buffett's holding company Berkshire Hathaway. The Warren Buffett Holdings theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Warren Buffett Holdings Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Hookipa Pharma is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Hookipa Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Hookipa Pharma Stock. Highlighted below are key reports to facilitate an investment decision about Hookipa Pharma Stock:
Check out Risk vs Return Analysis.
For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
To fully project Hookipa Pharma's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Hookipa Pharma at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Hookipa Pharma's income statement, its balance sheet, and the statement of cash flows.
Potential Hookipa Pharma investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Hookipa Pharma investors may work on each financial statement separately, they are all related. The changes in Hookipa Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Hookipa Pharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.